Fatty alcohol esters
Sigma Aldrich Fine Chemicals Biosciences Citronellyl acetate >=95%, FCC, FG | 150-84-5 | MFCD00015039 | 20KG
Citronellyl acetate >=95%, FCC, FG | Purity: >=95% | Mol Wt: 198.3 | 150-84-5 | MFCD00015039 | 20KG
eMolecules 2432-87-3 | Di-n-octyl sebacate | Combi-Blocks | MFCD00059269 | 426.682 | C26H50O4 | 98.000 | CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC | 25g | 388717113
Di-n-octyl sebacate | Combi-Blocks | 2432-87-3 | MFCD00059269 | 426.682 | C26H50O4 | 98.000 | CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC | 25g | 388717113
![eMolecules 3375-31-3 | Palladium acetate | Combi-Blocks | MFCD00012453 | 224.510 | C4H6O4Pd | 98.000 | [Pd++].CC([O-])=O.CC([O-])=O | 10g | 249356718](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000170606.jpg-250.jpg)
eMolecules 3375-31-3 | Palladium acetate | Combi-Blocks | MFCD00012453 | 224.510 | C4H6O4Pd | 98.000 | [Pd++].CC([O-])=O.CC([O-])=O | 10g | 249356718
Palladium acetate | Combi-Blocks | 3375-31-3 | MFCD00012453 | 224.510 | C4H6O4Pd | 98.000 | [Pd++].CC([O-])=O.CC([O-])=O | 10g | 249356718
Medchemexpress LLC Semaglutide acetate | 1997361-85-9 | 99.9% | 10 MG
Semaglutide acetate is a long-acting, selective GLP-1R agonist that penetrates the blood-brain barrier. It promotes insulin secretion, inhibits gastric emptying, and regulates lipid metabolism. This compound aids in lowering blood sugar, reducing weight, and improving hepatic steatosis. It is primarily researched for neurodegenerative diseases, type 2 diabetes, obesity, Parkinson's disease, and metabolic associated fatty liver disease (MASLD).
- Long-acting, selective GLP-1R agonist
- Penetrates blood-brain barrier
- Promotes insulin secretion, inhibits gastric emptying
- Enhances autophagy, inhibits apoptosis
- Regulates lipid metabolism, lowers blood sugar
- Reduces weight, improves hepatic steatosis
- Provides neuroprotection
- Researched for diabetes, obesity, Parkinson's disease, MASLD
- Anti-tumor and anti-proliferation activity
FUJIFILM Biosciences Methylazxymethanl Acetate MAM
Methylazoxymethanol Acetate MAM is used in preparation of model animals of schizophrenia as it reduces neurogenesis when administered in rats etc In patients with psychiatric disorders such as schizophrenia attenuation of sensory filter function that shuts unnecessary noises in the surroundings out of consciousness is observed This sensory filter function may be evaluated by a physiological test known as prepulse inhibition PPI weakening reaction to frightening sounds The decrease in this PPI is correlated to decrease in neurogenesis For research use only RUO
Cayman Chemical DLTryptophn octyl esTRhy 500mg
A stable, cell-permeable tryptophan derivative with an octyl ester protected COOH group
Cayman Chemical DL-Tryptophn octyl esterhy 5g
A stable, cell-permeable tryptophan derivative with an octyl ester protected COOH group
TARGETMOL CHEMICALS INC OCTREOTIDE ACETATE 100MG
Also available in 5 mg 10 mg 25 mg 50 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Octreotide Acetate (Sandostatin) is a potent long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone. purity: 99%
Sigma Aldrich Fine Chemicals Biosciences Linalyl acetate natural 961KG
Linalyl acetate is a monoterpene ester mainly found in lavandula essential oil. It is used as a flavoring agent in food industries as well as a preservative additive in cosmetics and fragrances such as soaps colognes perfumes and skin lotions.
Cayman Chemical a-hydroxy Farnesyl Phosphonic
α-hydroxy Farnesyl phosphonic acid is a nonhydrolyzable analog of farnesyl pyrophosphate which acts as a competitive inhibitor of farnesyl transferase (FTase).{1199,5456} At concentrations greater than 1 µM, α-hydroxy farnesyl phosphonic acid inhibits the processing of Ras in Ha-ras-transformed NIH3T3 cells.{1196}
Medchemexpress LLC Ulipristal acetate | 126784-99-4 | 99.9% | 475.62 | 50 MG
Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). It stimulates the autophagic response selectively in leiomyoma cells and has the potential for treating benign gynecological conditions such as uterine myoma.
- Orally active, selective progesterone receptor modulator (SPRM).
- Stimulates the autophagic response selectively in leiomyoma cells.
- Potential for benign gynecological conditions treatment, such as uterine myoma.
- Exhibits significant antiprogestational activity in vivo.
- Decreases incidences of fibroadenomas and adenocarcinomas in the mammary gland in all treated groups.
- Increases the frequency with which pathologists assessed the endometrium as being thickened in a dose-dependent manner.